etoposide has been researched along with Eaton-Lambert Myasthenic Syndrome in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dean, S; Herath, D; Kosmider, S; McCracken, J | 1 |
| Beckles, M; Chao, D; Lang, B; McCabe, DJ; Ng, K; Simister, RJ | 1 |
| Lachmann, E; Lin, JT | 1 |
| Fujita, T; Honoki, H; Inomata, M; Kashii, T; Kawagishi, Y; Kobayashi, M; Maruyama, M; Matsui, S; Miwa, T; Oda, H | 1 |
| Braig, G; Brueck, M; Kramer, W; Vogel, S; Waeger, S | 1 |
| Amano, H; Ishigatsubo, Y; Kakemizu, N; Kaneko, T; Kobayashi, M; Komatsu, S; Matsuse, T; Mishima, W; Miura, K; Miyashita, A; Nishihira, R; Nishiyama, H; Noda, K; Saito, H; Satoh, T; Shinohara, T; Tsukiji, J; Yamakawa, Y | 1 |
| Titulaer, MJ; van Gerven, J; Verschuuren, JJ; Willems, LN; Wirtz, PW | 1 |
| Kishimoto, R; Matsushima, M; Motomura, M; Nakadate, M; Sasaki, H; Shiraishi, H; Tsuji, S; Yabe, I; Yaguchi, H | 1 |
| Arakawa, M; Koike, R; Nagai, H; Takano, H; Tanaka, M; Tsuji, S | 1 |
| Billy, C; Carette, MF; Ferroir, JP; Milleron, B; Nahum, L; Ropert, A; Tcherakian, S | 1 |
2 review(s) available for etoposide and Eaton-Lambert Myasthenic Syndrome
| Article | Year |
|---|---|
Lambert-eaton myasthenic syndrome: a case report and review of the literature.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Respiratory Distress Syndrome | 2002 |
Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Antineoplastic Agents; Carcinoma, Small Cell; Cholinesterase Inhibitors; Cisplatin; Etoposide; Guanidine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Parasympathomimetics; Plasmapheresis; Potassium Channel Blockers; Prednisolone; Pyridostigmine Bromide; Randomized Controlled Trials as Topic | 2006 |
8 other study(ies) available for etoposide and Eaton-Lambert Myasthenic Syndrome
| Article | Year |
|---|---|
Lambert-Eaton myasthenic syndrome developing post-diagnosis of small-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carboplatin; Diagnosis, Differential; Disease Progression; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Neoplasm Staging; Neurologic Examination; Prognosis; Small Cell Lung Carcinoma; Terminal Care | 2018 |
Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Opsoclonus-Myoclonus Syndrome; Small Cell Lung Carcinoma | 2011 |
[Marked improvement of Lambert-Eaton myasthenic syndrome resulting from treatment for small cell lung carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Inappropriate ADH Syndrome; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male | 2003 |
[Lambert-Eaton myasthenic syndrome with acute respiratory failure associated with small cell lung cancer].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Cisplatin; Diagnosis, Differential; Electromyography; Etoposide; Fatal Outcome; Female; Humans; Immunization, Passive; Inappropriate ADH Syndrome; Lambert-Eaton Myasthenic Syndrome; Lung; Lung Neoplasms; Middle Aged; Neurologic Examination; Palliative Care; Respiratory Insufficiency; Tomography, X-Ray Computed | 2004 |
[A case of cT0N2M0 small cell lung cancer with Lambert-Eaton myasthenic syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Calcium Channels; Carboplatin; Carcinoma, Small Cell; Electromyography; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male | 2004 |
[Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
Topics: 4-Aminopyridine; Amifampridine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Pyridostigmine Bromide; Treatment Outcome | 2007 |
Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
Topics: Action Potentials; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Channels; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Muscles; Plasmapheresis | 1994 |
[Atypical paraneoplastic myasthenic syndrome: Lambert-Eaton syndrome or myasthenia?].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Lung; Lung Neoplasms; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes; Radiotherapy Dosage; Tomography, X-Ray Computed | 1999 |